Literature DB >> 28545008

Psychiatric disorders in a cohort of individuals with Prader-Willi syndrome.

L Shriki-Tal1, H Avrahamy2, Y Pollak3, V Gross-Tsur3, L Genstil2, H J Hirsch2, F Benarroch4.   

Abstract

BACKGROUND: Psychiatric manifestations in Prader-Willi Syndrome (PWS) are common and often are the most debilitating problem in these individuals. We present an epidemiological nation-wide survey of psychiatric diagnoses in the PWS population, based on full-range psychiatric interviews.
METHODS: We studied the distribution of psychiatric diagnoses (as opposed to a symptom-based approach) in the Israel national cohort of adolescents and adults with PWS. There was a total of 53 (32 males) ages 12 years and older. All individuals and their caretakers were interviewed using standardized psychiatric questionnaires. Demographic and clinical variables, Clinical Global Impression (CGI) score, IQ, severity of hyperphagia and quality of life (QOL) were also assessed and correlations with NPD (number of psychiatric diagnoses) calculated.
RESULTS: An overwhelming majority (89%) of the study participants had at least one psychiatric diagnosis. The most common were disruptive behavior disorders (DBD) (68%), obsessive compulsive disorder (OCD) (45%) and skin picking (35%). Individuals with DBD were at increased risk for OCD and skin picking. Psychotic disorders were found in 11%. NPD had a significant negative influence on QOL. There was no correlation between NPD and BMI, IQ, hyperphagia severity, hormonal profile or genetic subtypes.
CONCLUSIONS: Psychiatric diagnoses are very frequent in PWS and strongly influence QOL. Furthermore, characterizing the profile of psychiatric comorbidity in PWS is crucial for planning effective interventions. Precise behavioral phenotyping in PWS in combination with a well-defined genetic etiology may aid biological research linking biological correlates to behavior.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Behavior; Prader–Willi syndrome; Psychiatry

Mesh:

Year:  2017        PMID: 28545008     DOI: 10.1016/j.eurpsy.2017.03.007

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  6 in total

1.  Prader-Willi syndrome genetic subtypes and clinical neuropsychiatric diagnoses in residential care adults.

Authors:  A M Manzardo; N Weisensel; S Ayala; W Hossain; M G Butler
Journal:  Clin Genet       Date:  2018-02-05       Impact factor: 4.438

2.  Brief Report: Challenging Behaviors in Toddlers and Preschoolers with Angelman, Prader-Willi, and Williams Syndromes.

Authors:  Wei Siong Neo; Bridgette L Tonnsen
Journal:  J Autism Dev Disord       Date:  2019-04

3.  Associations Between Hyperphagia, Symptoms of Sleep Breathing Disorder, Behaviour Difficulties and Caregiver Well-Being in Prader-Willi Syndrome: A Preliminary Study.

Authors:  Jessica Mackay; Gillian M Nixon; Antony R Lafferty; Geoff Ambler; Nitin Kapur; Philip B Bergman; Cara Schofield; Chris Seton; Andrew Tai; Elaine Tham; Komal Vora; Patricia Crock; Charles Verge; Yassmin Musthaffa; Greg Blecher; Daan Caudri; Helen Leonard; Peter Jacoby; Andrew Wilson; Catherine S Choong; Jenny Downs
Journal:  J Autism Dev Disord       Date:  2021-09-08

4.  Syndrome-Related Risk Factors for Sexual Abuse: The Example of Prader-Willi Syndrome.

Authors:  Fortu Benarroch; Naama Srebnik-Moshe; Harry J Hirsch; Larry Genstil; Dvorit Derei; Anna Shay; Varda Gross-Tsur
Journal:  Arch Sex Behav       Date:  2021-06-29

Review 5.  A cross-comparison of cognitive ability across 8 genomic disorders.

Authors:  Michael Mortillo; Jennifer G Mulle
Journal:  Curr Opin Genet Dev       Date:  2021-05-31       Impact factor: 4.665

6.  The adult phenotype of Schaaf-Yang syndrome.

Authors:  Felix Marbach; Magdeldin Elgizouli; Megan Rech; Jasmin Beygo; Florian Erger; Clara Velmans; Constance T R M Stumpel; Alexander P A Stegmann; Stefanie Beck-Wödl; Gabriele Gillessen-Kaesbach; Bernhard Horsthemke; Christian P Schaaf; Alma Kuechler
Journal:  Orphanet J Rare Dis       Date:  2020-10-19       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.